NDV-D90 suppresses growth of gastric cancer and cancer-related vascularization.
Sui, Hong; Wang, Kaibing; Xie, Rui; Li, Xi; Li, Kunpeng; Bai, Yuxian; Wang, Xishan; Bai, Bin; Chen, Dan; Li, Jiazhuang; Shen, Baozhong.
; 8(21): 34516-34524, 2017 May 23.
Artigo em Inglês | MEDLINE | ID: mdl-28388537
Immunotherapy for Gastric Cancer: Time for a Personalized Approach?
Insights into next developments in advanced gastric cancer.
Familial gastric cancer: genetic susceptibility, pathology, and implications for management.
Mouse models for gastric cancer: Matching models to biological questions.
RNA interference in the progress of gastric cancer.
The Italian Research Group for Gastric Cancer (GIRCG) guidelines for gastric cancer staging and treatment: 2015.
Radiotherapy for gastric cancer: a systematic review and meta-analysis.
Tumor regression grade in gastric cancer: Predictors and impact on outcome.
Lentivirus-mediated RASSF1A expression suppresses aggressive phenotypes of gastric cancer cells in vitro and in vivo.
[GASTRIC CANCER IN THE PRACTICE OF FAMILY PHYSICIAN].